Crossmark

Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”

Crossref DOI link: https://doi.org/10.1007/s12072-024-10682-6

Published Online: 2024-07-08

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zeng, Zhen-Xin

Wu, Jia-Yi

Zhuang, Shao-Wu

Yan, Mao-Lin https://orcid.org/0000-0002-9852-2661
License Information

Text and Data Mining valid from 2024-07-08

Version of Record valid from 2024-07-08
More Information

Article History

Received: 21 March 2024

Accepted: 6 April 2024

First Online: 8 July 2024

Declarations

:

: Zhen-Xin Zeng, Jia-Yi Wu, Shao-Wu Zhuang, Mao-Lin Yan have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below